Filing Flows › Industrials › Astrana Health (ASTH)
Astrana Health (ASTH) earnings and revenue breakdown
Latest: Q3 2026 · 10-Q filed Nov 6, 2026 · Astrana Health (ASTH) Q3 2026 earnings results →
Q3 2026 Revenue up 7% year over year to $1.0B · 1¢ of every $1 of revenue kept as net profit · operating margin 3.9%
Astrana Health made $1.0B in Q3 2026 (+7% Y/Y): Health Care Capitation Revenue $937M, Health Care Patient Service $35.1M, Health Care Other $24.3M. Operating margin 3.9%, net earnings $13.0M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 6, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $1.0B in Q3 2026, up 7% year over year and up 5% from the previous quarter. Health Care Capitation Revenue was the largest line at 92% of revenue. Health Care Capitation Revenue added $0.07B year over year (up 8%), 108% of the total change. Health Care Other declined 21%.
Operating profit was $0.04B, a 3.9% margin (up 1.9 points year over year). Of the extra revenue versus Q3 2025, 31% reached operating profit, above the 2% margin then. Total costs grew 5% against revenue growth of 7%. Net earnings were $0.01B, up 3372% year over year. The effective tax rate was 37.1%.
Operating cash flow was $0.02B (up 63% year over year), 80% of net income including minority interests. Non-cash charges added back $0.02B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.04B. Capital expenditures of $3.8M left free cash flow of $0.01B.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 10-Q | Nov 6, 2026 | $1.0B | +7% | 3.9% | $13.0M | $16.3M |
| Q2 2026 | 10-Q | Aug 10, 2026 | $973M | +48% | 3.5% | $19.7M | $32.7M |
| Q1 2026 | 10-Q | May 8, 2026 | $965M | +56% | 3.0% | $14.4M | $68.1M |
| Q4 2025 | 10-K | Mar 12, 2026 | $951M | +43% | 1.9% | $6.0M | −$2.9M |
| Q3 2025 | 10-Q | Nov 10, 2025 | $956M | +100% | 2.0% | $373K | $10.0M |
| Q2 2025 | 10-Q | Aug 7, 2025 | $655M | +35% | 3.1% | $9.4M | $90.9M |
| Q1 2025 | 10-Q | May 9, 2025 | $620M | +53% | 3.3% | $6.7M | $16.6M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Customers and suppliers named in filings
Sells to
- Medicare & Medicaid · Stated in 10-K (XBRL) · source
About Astrana Health
Astrana Health is a physician-centric, AI-powered healthcare company committed to delivering high-quality, patient-centered care. Built from the physician's perspective, Astrana combines its scalable care delivery infrastructure, proprietary technology platform, and aligned provider networks to enable proactive, preventive care at scale - improving patient outcomes, enhancing patient experiences, supporting provider well-being, and driving greater value across the healthcare system. Today, Astrana supports more than 20,000 providers and approximately 1.5 million patients in value-based care arrangements through its affiliated provider networks, management services organization, and integrated care delivery clinics spanning primary, specialty, and ancillary care.
In its own words, from its 8-K, filed Aug 6, 2026.
Astrana Health against its Services-Management Consulting Services peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +7% against the peers' median +6%. Operating margin: 3.9% against the peers' median 8.9%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| ASTH Astrana Health | Q3 2026 | $1.0B | +7% | 3.9% |
| BAH Booz Allen Hamilton Holding | Q2 FY27 | $2.8B | -4% | 8.8% |
| G Genpact | Q3 2026 | $1.4B | +7% | 15.2% |
| FCN FTI Consulting | Q3 2026 | $1.0B | +6% | 8.9% |
| HURN Huron Consulting Group | Q3 2026 | $491M | +11% | 12.0% |
| ICFI ICF International | Q3 2026 | $470M | +1% | 9.3% |
| ONT Onterris | Q3 2026 | $203M | -10% | 6.0% |
| EXPO Exponent | Q3 2026 | $174M | +18% | 24.1% |
| RMR RMR Group | Q3 FY26 | $154M | -0.8% | -6.0% |
Source: Astrana Health 10-Q on SEC EDGAR · CIK 1083446 · Services-Management Consulting Services
Guidance and outlook
13F: who owns ASTH and who is buying
More on ASTH
- How Astrana Health makes money: revenue by segment
- Astrana Health next earnings date and what analysts expect
- Astrana Health stock forecast, price target and fair value
- Who owns Astrana Health stock: holders, funds and Congress trades
- Astrana Health guidance and outlook
- Is Astrana Health a takeover target? LBO and rumors
History
Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results
- Astrana Health operating margin by quarter
- Astrana Health net income by quarter
- Astrana Health free cash flow by quarter
- Astrana Health capital expenditures by quarter
- Astrana Health Health Care Capitation Revenue revenue by quarter
- Astrana Health Health Care Patient Service revenue by quarter
- Astrana Health Health Care Other revenue by quarter